July 28, 2023
- June 20, 2023 - Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed). See NOFO RFA-HG-23-024.
- June 20, 2023 - Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed. See NOFO RFA-HG-23-025.
National Human Genome Research Institute (NHGRI)
The purpose of this Notice is to change the dates of the scientific merit and national advisory council dates for: (1) Limited Competition: High Quality Reference Genomes (UM1 Clinical Trial Not Allowed) RFA-HG-23-024 and (2) Limited Competition: Human Pangenome Coordinating Center (U41) Clinical Trial Not Allowed RFA-HG-23-025.
Currently Reads:
Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| Not Applicable | August 15, 2023 | Not Applicable | March 2024 | May 2024 | July 2024 |
Revised to Read:
Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
New | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| Not Applicable | August 15, 2023 | Not Applicable | November 2023 | Feb 2024 | April 2024 |
There are no other changes to these NOFOs.
Adam L. Felsenfeld, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-496-7531
Email: [email protected]
and Human Services (HHS)
